Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06206148 · ClinicalTrials.gov registry record · NA
Comparison of Methods for Recording Post Operative Pain
A NA study of Pain, Postoperative, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 147
- Enrollment target
- 1
- Study location
NCT06206148: Recruiting NA study of Pain, Postoperative, sponsored by University of California, San Francisco.
NCT06206148 is a NA study of Pain, Postoperative that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 147 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06206148, a NA study of Pain, Postoperative, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the current study is to identify the optimal method of collection of pain intensity data. The study will compare three collection methods: a hand-written pain journal, a smartphone app, and a novel electronic pain recorder device. Patients will be randomly assigned to one of three methods and instructed to record their pain level as often as they like. The number of pain intensity recordings per day will then be compared across groups.
Primary Outcome
Pain Scores will be measured on the Visual Analog Scale (VAS) via 3 different methods to determine the best way to collect pain intensity data. The Visual Analog Scale goes from 0-10 where 0 means no pain and 10 means maximum pain.
Conditions Studied
Interventions
- OTHER Smartphone app
- DEVICE Given novel electronic pain recording device
- OTHER Given Hand-written pain journal
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06206148 shows while recruiting
NCT06206148 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Smartphone app is the first listed.
NCT06206148 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06206148 about?
NCT06206148 is a clinical study titled "Comparison of Methods for Recording Post Operative Pain". The purpose of the current study is to identify the optimal method of collection of pain intensity data. The study will compare three collection methods: a hand-written pain journal, a smartphone app, and a novel electronic pain recorder device. Patients will be randomly assigned to one of three met...
What is the current status of trial NCT06206148?
This trial is currently recruiting. It is a NA study. The enrollment target is 147 participants. The study started on 2024-03-01. Estimated completion is 2026-06.
What conditions does trial NCT06206148 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT06206148?
The interventions under investigation include: Smartphone app (OTHER), Given novel electronic pain recording device (DEVICE), Given Hand-written pain journal (OTHER).
Who is sponsoring clinical trial NCT06206148?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06206148 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06206148's enrollment target sits among peer trials
147 28th of 113 higher than 85 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Dance Study for Post-surgical Pain in Breast Cancer Survivors
RECRUITING · NA
-
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
RECRUITING · NA
-
Anesthetic Optimization in Pediatric LeFort Surgeries
RECRUITING · NA
-
Latinx Children and Surgery
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI